{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21226 Prescribing of medicines policy.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "PRESCRIBING OF MEDICINES POLICY"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-21226"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff involves in the prescribing of medicines"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "14 December 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "13 December 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet:"
                    },
                    {
                        "text": "Prescribing, NMP, medication, prescription, drug"
                    },
                    {
                        "text": "Developed in response to: (National Guidance/Recommendations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "NPSA and NHSE Medication Patient Safety Alerts RPS 2021:"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Care group/division:"
                    },
                    {
                        "text": "Division 9 / Pharmacy"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Medication Safety Officer / Principal Pharmacist Medication Safety."
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Medicines Assurance Group Chair action A.Kabir"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Evelyn Allen"
                    },
                    {
                        "text": "Chief Pharmacist"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "14 December 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "January 22"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-21226 Prescribing of medicines policy.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 12,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Simon Worrall"
                    },
                    {
                        "text": "Deputy Chief Pharmacist"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Tomi Tommy-Uffang"
                    },
                    {
                        "text": "Pharmacy Head of Department, Southend"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Fatemeh Leedham"
                    },
                    {
                        "text": "Pharmacy Head of Department, Basildon"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Alison Felton"
                    },
                    {
                        "text": "Pharmacy Head of Department, Broomfield"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Laura Hilton"
                    },
                    {
                        "text": "NMP Lead, Southend / HIV Nurse Consultant"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Jane Young"
                    },
                    {
                        "text": "NMP Lead, Broomfield, Diabetes Consultant Nurse, MSE & PROVIDE"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Sarah Fairclough"
                    },
                    {
                        "text": "NMP Lead, Basildon, Liver Nurse Specialist"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Dr Alamgir Kabir"
                    },
                    {
                        "text": "Clinical Director Essex CTC and MSE Cardiology"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Dr Sudhakaran Makkuni"
                    },
                    {
                        "text": "Consultant Haematologist, Basildon"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Dr Samudra Mukherjee"
                    },
                    {
                        "text": "Consultant Paediatrician, Basildon"
                    },
                    {
                        "text": "07 December 2021"
                    },
                    {
                        "text": "Dr Shilpa Selvan"
                    },
                    {
                        "text": "Consultant Rheumatologist, Basildon"
                    },
                    {
                        "text": "07 December 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Group if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Medicines Assurance Group (as per page 1) Chair action"
                    },
                    {
                        "text": "07 December 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "MSEPO-21206 Safe Handling of Medicines Policy MSEPO-21079 Non-medical prescribing policy MSEPO-21085 Verbal Prescribing Orders Policy and Procedures MSBPO-18017 Unlicensed Medicines Policy MSEPO-20237 Controlled Drugs Policy MSEPO-20204 Safe Handling Effective Use and Management of IMPs MSEPO-21144 Discharge TTA medication Policy MSBPO-20206 Policy for the Management of and Learning from Medication Error Incidents MSEPO-20210 Development Approval and Implementation of PGDs Policy MSEPO-20211 Discretionary medicines administration policy MSEPO- 21087 Dealing with Pharmaceutical Company Representatives and Drug Samples Policy MSEPO-21005 FP10 Prescription Policy and Procedures MSEPO-21054 Policy for Management of Antimicrobials MSEPO-21083 Access to medication and advice outside of pharmacy opening hours MSEPO-21090 Medicines Reconciliation Policy MSEPO-21105 Conscious Sedation Policy MSEPO-21128 Administration of medicines policy MSEPO-21089 Vinca Alkaloids Policy MSEPO-21088 Management of IntraTHECAL Chemotherapy Policy MSEPO-20239 Clinical record keeping standards policy MSBPO-18020 Allergy status management Policy Policy for Safe Prescribing, Handling and Administration of Systemic Anticancer Therapy (or equivalent) Acute opiate analgesia policies & guidelines, or equivalent Entonox policy, or equivalent Oxygen policy, or equivalent Venous Thromboembolism (VTE) Policy, or equivalent"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 5,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Rev iewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "14 December 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Safe and secure handling of medicines section 15 & 18."
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role & responsibilities within the Trust ......................................................................... 7"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Persons with authority to prescribe and prescriber accountability .............................. 11"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Prescriber competency ............................................................................................... 12"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Authority to prescribe medication types ...................................................................... 12"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Formulary prescribing ................................................................................................. 14"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 32.0,
                "text": "Prescriber expectations and clinical prescribing considerations ................................. 15  General principles for using ePMA and paper drug charts ......................................... 18  Prescribing requirements for inpatient drug charts ..................................................... 20  Requirements for each prescribed medicine .............................................................. 20  Discontinuation, cancellations and alterations to a prescription .................................. 23  Prescribing non-daily medicines ................................................................................. 24  Antimicrobial therapy .................................................................................................. 25  Steroid therapy ........................................................................................................... 25  Medicines subject to pregnancy prevention programmes (PPPs) .............................. 26  Intravenous infusion therapy ....................................................................................... 26  Controlled Drugs ......................................................................................................... 28  Oral and injectable anticoagulants .............................................................................. 28  Insulin ......................................................................................................................... 29  Prescribing for outpatients .......................................................................................... 30  Self-prescribing and for other hospital staff ................................................................ 31  Private prescriptions ................................................................................................... 32  Prescribing amendments (Pharmacy and Nursing/Midwifery) .................................... 33 Prescribing errors and incidents ................................................................................. 34  Prescribing concerns .................................................................................................. 34  Training requirements ................................................................................................. 35  Monitoring and audit ................................................................................................... 35  Approval and implementation ..................................................................................... 36  Equality impact assessment ....................................................................................... 36  References ................................................................................................................. 36 Appendix 1: Acceptable Prescribing Abbreviations ............................................................ 39 Appendix 2: Preliminary Equality Analysis ......................................................................... 40"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "The prescribing of medicines for patients is the most common intervention made as part of the treatment provided to patients during a hospital admission. Medicines are prescribed to promote health, healing and/or well-being of patients. They can, however, be harmful to patients if prescribed, dispensed or administered incorrectly or if patients suffer adverse reactions."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "Prescribing requires a collaborative effort between all healthcare professionals and the patient. These are not mechanistic tasks to be performed routinely; they require thought and the exercise of professional judgement."
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "Medicines must be prescribed in a manner which is clearly understood by the prescriber, pharmacist and practitioner administering the medication. The prescriber must not prescribe medicines beyond their competence."
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "This policy informs all staff on the principles of prescribing. This policy applies to all professionals involved in prescribing and must be followed alongside MSEPO- 21079 Non-medical prescribing policy."
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.5,
                "text": "The specific requirements of specialist clinical areas may not be covered in this document and these may necessitate more detailed local procedures. These are the responsibility of the relevant division and speciality and such procedures may need approval by the department of pharmacy before implementation."
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this document is to:"
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Outline the framework to ensure that all medicines are prescribed in a safe, accurate and complete manner; which is in compliance with all professional, safety directives and legal requirements."
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Provide guidance to all Trust staff on the procedures relating to the prescribing of medicines."
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To provide a governance framework for this element of medicines management in the Trust, thereby improving patient safety."
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "This policy does not cover discharge prescription prescribing. Refer to MSEPO- 21144 Discharge TTA medication Policy."
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.3,
                "text": "This policy does not cover some specialist prescribing and many specialist medicines Trust policies exist. Please refer to \u2018Related Trust Policies' section above. This list is not exhaustive."
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "type": "table",
            "sequence_num": 32,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "AED"
                    },
                    {
                        "text": "Anti-epileptic drug."
                    },
                    {
                        "text": "BNF"
                    },
                    {
                        "text": "British National Formulary."
                    },
                    {
                        "text": "CDS"
                    },
                    {
                        "text": "Clinical Decision Support."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 33,
            "data": {
                "num_rows": 20,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Controlled Drug"
                    },
                    {
                        "text": "Controlled Drug. A drug to which its possession, supply and use are restricted by law and its possession may be an offence. Restrictions are described by what \u2018Schedule' the drug is categorised under."
                    },
                    {
                        "text": "DOAC /NOAC"
                    },
                    {
                        "text": "Direct Oral Anticoagulant / Non-VKA Oral Anticoagulant."
                    },
                    {
                        "text": "ePMA"
                    },
                    {
                        "text": "Electronic prescribing and medicines administration."
                    },
                    {
                        "text": "GSL medicine"
                    },
                    {
                        "text": "General Sales List medicine."
                    },
                    {
                        "text": "HCPC"
                    },
                    {
                        "text": "Health and Care Professions Council."
                    },
                    {
                        "text": "INR"
                    },
                    {
                        "text": "International Normalised Ratio."
                    },
                    {
                        "text": "LMWH"
                    },
                    {
                        "text": "Low-molecular weight heparin."
                    },
                    {
                        "text": "Medicine"
                    },
                    {
                        "text": "\u2018Medicinal product' defined under Medicines Act 1968: That is, any substance administered for treating, preventing or diagnosing disease, for contraception, for inducing anaesthesia or modifying a normal physiological function. Medical gases are medicinal products."
                    },
                    {
                        "text": "NMC"
                    },
                    {
                        "text": "Nursing and Midwifery Council."
                    },
                    {
                        "text": "P medicine"
                    },
                    {
                        "text": "\u2018Pharmacy-only' medicine."
                    },
                    {
                        "text": "PGD"
                    },
                    {
                        "text": "Patient group direction."
                    },
                    {
                        "text": "Pharmacist clinical screen / verification"
                    },
                    {
                        "text": "This is a check of a patient's prescription to ensure the appropriateness of all medication prescribed e.g. indications, doses, interactions, route of administration, formulations, appropriate monitoring. This is in accordance with specific pharmacy departmental procedures."
                    },
                    {
                        "text": "PPP"
                    },
                    {
                        "text": "Pregnancy prevention programme"
                    },
                    {
                        "text": "PRN"
                    },
                    {
                        "text": "\"pro re nata\"; as needed / when necessary."
                    },
                    {
                        "text": "Regular medicine"
                    },
                    {
                        "text": "Medicines prescribed on the main part of the drug chart, denoting continual dosing (i.e. every morning, twice daily) etc."
                    },
                    {
                        "text": "rINN"
                    },
                    {
                        "text": "recommended International Non-proprietary Name."
                    },
                    {
                        "text": "STAT"
                    },
                    {
                        "text": "Once only, give immediately."
                    },
                    {
                        "text": "TPN"
                    },
                    {
                        "text": "Total parenteral nutrition."
                    },
                    {
                        "text": "TTA / TTO"
                    },
                    {
                        "text": "To take away / To take out \u2013 these interchangeable terms refer to prescribed discharge medication."
                    },
                    {
                        "text": "VKA"
                    },
                    {
                        "text": "Vitamin-K antagonist."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role & responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "MSE Quality Governance Group (QGG)"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Receiving exception reports and taking action in response to issues raised from Medicines Assurance Group and/or department of pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "MSE Medicines Assurance Group (MAG)"
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring the effective implementation, use and timely review of this policy;"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that monitoring arrangements are appropriately performed by the Medicines Optimisation and Safety Group (MOSG);"
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Approving and reviewing mechanisms for medicines optimisation in line within its terms of reference;"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring shared prescribing pathways across the integrated care system are implemented within the MSE Trust;"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Approving entry of hospital-only new medicines or new uses for medicines onto the medicines formulary;"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring implementation of relevant NICE technology appraisals as appropriate;"
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where necessary, escalating concerns to the Chief Medical Officer and site Medical Directors or Chief Nurse and site Director of Nursing as appropriate;"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Exception reporting to the MSE Quality Governance Group on developments, concerns and progress concerning safe handling of medicines."
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "Medicines Optimisation and Safety Group (MOSG)"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monitoring this policy through incident reports;"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Identifying and co-ordinating shared learning from prescribing incidents;"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Escalating issues to site divisional governance groups and MAG as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "Non-medical prescribing forum"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring shared learning from prescribing incidents to non-medial prescribers and ensure engagement with prescribing practice;"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Escalating issues to MAG as appropriate."
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.5,
                "text": "MAG Subgroup for electronic prescribing and medicines administration (ePMA)"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Taking decisions and advising on the maintenance and development of Wellsky ePMA."
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.6,
                "text": "Chief Executive"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "As the Trust's accountable officer has overall responsibility for ensuring the Trust has robust, complete and up to date documents in place to govern and guide activities so that legal and national requirements are met."
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.7,
                "text": "Chief Medical Officer, site Medical Directors and divisional Medical and Clinical Directors, Chief Nursing Officer, site Directors of Nursing, Deputy Directors of Nursing, Director of Midwifery, Pharmacy Heads of Department"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance and liaising with the Chief & Deputy Chief Pharmacist, & MSE Medication Safety Officer that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring sufficient resources are in place to implement this policy;"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated prescribing issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.8,
                "text": "Chief Pharmacist"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Setting the overall framework and policy standards for prescribing of medicines across the organisation, in line with regulatory and best practice guidance;"
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring a monitoring process exists and functions for policy standards;"
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.8.1 As the Trust's named Accountable officer for controlled drugs they are responsible for ensuring that effective controls are in place for the storage and security of controlled drugs including handling and usage. Refer to MSEPO-20237 Controlled Drugs Policy."
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.8.2 The Chief Pharmacist delegates day-to-day responsibility to the site pharmacy Heads of Department and divisional principal clinical lead pharmacists for delivery"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "text": "and in ensuring the pharmacy site is monitoring prescribing practice, acting upon issues or concerns."
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.9,
                "text": "Prescribers"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.9.1 Prescribers are personally responsible for their own actions and omissions. When prescribing is delegated to another member of the multidisciplinary team, the practitioner who actually prescribes remains responsible."
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.9.2 All locums/ agency and Bank staff are expected to adhere to the same standards of practice as permanent staff. Such staff must be authorised to prescribe within the Trust as part of their contract to work."
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.9.3 Responsibilities are:"
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Undertaking relevant training in prescribing as set out by the Trust, ensuring they are competent to prescribe the medicine/s involved;"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Maintaining competency in accordance with national prescribing competency framework/s adopted by their profession regulatory body;"
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where a non-medical professional, working within the framework of MSEPO- 21079 Non-medical prescribing policy;"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Exercising professional judgement using acquired knowledge and skills when prescribing and administering medicines for the individual prescribing episode. This includes whether prescribing themselves or assisting or overseeing the prescribing of a medicine;"
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prescribing all medicines clearly with appropriate details to enable safe and accurate administration (dose, frequency etc.), in accordance with this document;"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reviewing and acting upon information provided by pharmacy and administering practitioners regarding medicines use and patient's regular medicines;"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Carrying out all related processes in accordance with their regulatory body guidance and any published standards for prescribing;"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For paper prescriptions signing all prescriptions and making clear as to their identity. The Trust requires a prescriber to print their name and contact/bleep number on all paper prescriptions for this purpose;"
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Understanding the indication, usual dose and frequency, monitoring requirements and side effects of all medicines they prescribe;"
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring all medicines prescribed are safe to be administered within the department the patient is being treated (i.e. is appropriate monitoring available?);"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Cancelling relevant prescriptions clearly and accurately in accordance with this document;"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Documenting all medication changes clearly, with reasons, within patient notes, on drug chart and ensure transcribed onto the discharge summary;"
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Informing the patient and counselling them on new medicines before initiation of treatment and recording this in patient notes;"
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Informing nursing staff (or equivalent) when a new medicine is prescribed to ensure prompt ordering/ administration of medicine;"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appropriately monitoring for effectiveness, toxicity and side effects of medications, following Trust procedures and clinical guidelines where indicated."
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Timely prescribing of medicines;"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reporting medication incidents."
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "Registered Pharmacists and Registered Pharmacy Technician"
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Undertaking tasks and accepting accountability for tasks undertaken in accordance with all pharmacy departmental procedures;"
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Exercising professional judgement using acquired knowledge and skills when reviewing, ordering and/or supplying medicines against a prescription;"
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Carrying out medicine reconciliation processes on patient admission in accordance with MSEPO-21090 Medicines Reconciliation Policy;"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where involved in clinically screening or ordering medicines, ensuring prescribing accuracy including the checking for appropriate drug names, dosing, frequency and safety with respect to the patient-specific information available to them(organ function etc.) Clinical aspects will be undertaken by registered pharmacists only, in accordance with their professional training;"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appropriately endorsing prescriptions and drug charts and escalating in a consistent and documented manner to other healthcare professionals;"
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Supporting the discharge process in accordance with MSEPO-21144 Discharge TTA medication policy"
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing specialist advice to other healthcare professionals on medicines use;"
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monitoring of prescribing quality and safety, noting and escalating anomalies to senior Trust pharmacy staff for investigation;"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reporting medication incidents."
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.11,
                "text": "Clinical Site Manager"
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where Wellsky ePMA has rolled-out:"
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing support, advice and act as trouble-shooters for prescribers using Wellsky ePMA out of hours (including resetting passwords, admitting / transferring or discharging patients from system);"
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Facilitating access to the Wellsky ePMA training and providing login details to locum/agency medical staff out of hours, where required."
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.12,
                "text": "Wellsky electronic prescribing and medicines administration (ePMA) service team"
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing support and advice to users of the Wellsky ePMA;"
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing access to training and manage access to the system;"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Producing guides and learning materials for the system;"
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Managing and maintaining all aspects of the system."
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.13,
                "text": "Local Security Management Specialist"
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Working with the Chief Pharmacist, or deputy, in response to investigations suspecting illegal prescribing practice or medicines supply diversion;"
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Involving professional and legal authorities, as appropriate in collaboration with professional Trust leaders."
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Persons with authority to prescribe and prescriber accountability"
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Medicines may be prescribed in the Trust by registered medical staff or registered non-medical prescribers (NMPs)."
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Provisionally registered medical staff may prescribe for inpatients including prescriptions for leave or discharge. They may not prescribe for outpatients, private patients, A&E patients, themselves, colleagues or members of their family."
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "The prescriber is accountable for all prescriptions bearing their signature (or electronic equivalent for ePMA), regardless of whether or not they were requested to prescribe by another healthcare professional (more senior or otherwise)."
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "Where a referral for an opinion to another medical/surgical team has taken place, the team in charge of care for the patient are responsible for ensuring the prescribing of any recommended treatment changes happens (i.e. as documented in the patient health record)."
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.5,
                "text": "Non-Medical Prescribers (NMPs)"
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.5.1 NMPs must meet specific requirements AND must only prescribe if authorised by the Trust in that specific defined job role. Please refer to MSEPO-21079 Non- medical prescribing policy."
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.5.2 NMPs must have undertaken and completed the approved course of study and be regulated by their professional body as a non-medical prescriber."
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.6,
                "text": "Medical Students"
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.6.1  Medical students are accountable for their own actions and omissions. Medical students are not permitted to prescribe under any circumstances though they may participate in medicines reconciliation. This must be under the direct supervision of a registered medical practitioner."
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.7,
                "text": "Pharmacy staff transcribing onto a discharge summary"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.1 Transcribing is not prescribing, as the original written prescription direction to supply exists and is made by an authorised prescriber."
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.2 Registered pharmacists or designated registered pharmacy technicians (i.e. near- patient technician with extra level of competency demonstrated) may transcribe inpatient prescription details onto a discharge summary, provided that the:"
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Wording of the original inpatient prescription is clear;"
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Wording of the original inpatient prescription fulfils the requirements of the detail of the TTA medicines required;"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Pharmacy team member is familiar with the patient, the ward and the prescriber;"
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prescriber is directly involved in writing, dispensing or checking the order;"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Person transcribing can demonstrate competency and is signed off by the site pharmacy department."
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.3 A second registered pharmacist or pharmacy technician must be directly involved to provide an accuracy check."
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 0,
                "text": "5.7.4 Where the prescriber is not known to the registered pharmacy staff, the prescription must not be transcribed."
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Prescriber competency"
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Prescribers must operate within the competency framework approved and endorsed by their professional regulatory body. These are the frameworks Trust staff must adhere to."
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Regulatory bodies (including the Nursing and Midwifery Council (NMC) and Health and Care Professions Council (HCPC)) have adopted the Royal Pharmaceutical Society (RPS) \u2018A Competency Framework for all Prescribers' (the Framework) (RPS, 2021) as its standards for all prescribers. Please refer to policy references. Individuals will have until September 2022 as a transition period to fully implement the framework in practice. This national framework is maintained by the RPS on behalf of NICE and Health Education England."
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "The competencies detailed in the Framework set out the knowledge, understanding and skills that a registrant must have when they complete their prescribing training and which they must continue to meet once in practice (RPS,2021)."
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.4,
                "text": "The framework should be used by prescribers to identify strengths and areas for development through self-assessment, appraisal and as a way of structuring feedback from colleagues."
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.5,
                "text": "At Trust organisational level this framework should be used to:"
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "text": "stimulate discussions around prescribing competencies and multidisciplinary skill mix;"
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 0,
                "text": "inform recruitment processes to help frame questions and benchmark candidates' prescribing experience;"
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 0,
                "text": "analyse the way individuals and the Trust does its job with respect to prescribing (RPS, 2021)."
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Authority to prescribe medication types"
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.1,
                "text": "For Controlled Drugs refer to MSEPO-20237 Controlled Drugs Policy."
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.2,
                "text": "For verbal prescribing orders refer to MSEPO-21085 Verbal Prescribing Orders Policy and Procedures."
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.3,
                "text": "For Unlicensed medicines and prescribing licensed medicines outside the terms of a product licence refer to MSBPO-18017 Unlicensed Medicines Policy."
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.4,
                "text": "Total Parenteral Nutrition (TPN)"
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.4.1  TPN is legally a prescription-only medicine. It must only be prescribed onto a drug chart by a registered competent prescriber (medical or NMP)."
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.5,
                "text": "Oral or enteral nutritional supplements and fluid thickeners"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.1 Treatment with oral nutritional supplements, enteral feeds and fluid thickeners may be advised upon by registered dietitians or speech and language therapists."
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.2 Registered dietitians may enter oral or enteral nutritional supplements onto the drug chart or Wellsky ePMA."
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.3 Registered Speech and Language Therapists may enter fluid thickener onto the drug chart or Wellsky ePMA."
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.4 These allied health professions must:"
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Be registered with the Health and Care Professions Council;"
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 0,
                "text": "be deemed suitably competent to undertake this activity by their line manager;"
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Add only those products included within the approved formulary;"
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Maintain records in the patient health record related to their dietary supplementation / thickener (as appropriate);"
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Be appropriately trained in use of ePMA and have their own login issued."
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.5 Entries on paper charts must state clearly their designation e.g. \u2018dietitian'."
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.6 Wellsky ePMA is configured to enable staff with grade Speech and Language Therapist to only be able to add the formulary choice thickener product."
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.7 Dietitians and Speech and Language therapists may not, however, write enteral nutritional supplements / thickeners directly on to any FP10 prescriptions."
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.6,
                "text": "Radioactive medicines for therapeutic and diagnostic purposes"
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.6.1  Please refer to MSEPO-21128 Administration of medicines policy which also covers the prescribing aspect."
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.7,
                "text": "Midwife exemptions"
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.7.1  Registered midwives may supply and administer specified medicines legally without a prescription under \u2018Midwives Exemptions'. Please refer to MSEPO-21128 Administration of medicines policy."
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.8,
                "text": "Patient Group Directions (PGD's) & written instructions"
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.8.1  Registered healthcare professionals have the authority to administer and supply certain medicines at their own discretion. This is not prescribing and the precise circumstances in which this is permitted will be defined in a PGD. Refer to MSEPO- 20210 Development Approval and Implementation of PGDs Policy."
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.9,
                "text": "Formal written instructions also exist in limited circumstances which are not prescriptions but a legal instruction to administer. Refer to MSEPO-21128 Administration of medicines policy."
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.1,
                "text": "Discretionary medicines"
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.10.1  Registered healthcare professionals have the authority to administer certain limited medicines, at their own discretion, which can alleviate the symptoms of minor ailments that patients may develop whilst in hospital such as constipation, pain, etc. Their legal classification is always General sales list (GSL) or Pharmacy (P). This is not prescribing and the precise circumstances in which these are permitted are defined in MSEPO-20211 Discretionary medicines administration policy."
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.11,
                "text": "Complementary and alternative medicines"
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 1,
                "text": "7.11.1 Most complementary/alternative medicines are not legally controlled. However there are several preparations that may affect the action of prescribed medication, or which could be associated with adverse effects. It is important that if a patient wishes to use an alternative medicine the safety is checked with the pharmacist and the prescriber responsible for the patient prior to prescribing."
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 1,
                "text": "7.11.2 If the prescribing team responsible for the patient are satisfied with the safety of the product, and wish the patient to use it during the admission, it must be prescribed on the Trust drug chart. For Wellsky ePMA this can be entered on as an \u2018unknown drug' with a note. The prescriber is wholly accountable for this prescription."
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "data": {
                "is_heading": 1,
                "text": "7.11.3 Complementary and Alternative Medicines are generally not acceptable for initiation unless explicitly documented otherwise in local protocols and the medicines formulary."
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Formulary prescribing"
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "All medical and non-medical prescribers are expected to prescribe within the agreed medicines formulary."
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Pharmacy does not routinely stock non-formulary medicines and prescribing clinicians must be aware that such medicines may be unavailable and/or unobtainable. Where obtainable there could also be delays of up to 72 hours before stock can be obtained. This delay may be longer at weekends or Bank Holidays."
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "It is not acceptable to ask other prescribers e.g. GPs to take on the prescribing of medicines that are non-formulary. Requests are likely to be refused, and are reported back to the Trust."
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.4,
                "text": "Prescribing for patients admitted to hospital on non- formulary medication"
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.4.1 Non-formulary medicines included within an agreed therapeutic substitution protocol should have their medication substituted."
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.4.2 For all other non-formulary items for patients stabilised on therapy will initially be screened by designated registered pharmacists and a decision may be taken to"
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 0,
                "text": "supply at that point. This decision will consider clinical need, cost effectiveness and ongoing approval across the integrated care system. If a decision cannot be made in pharmacy the decision will be referred to the site Medical Director or nominated deputy for decision."
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 1,
                "text": "8.4.3 If on discussion with the requesting clinician any immediate and significant risk to patient safety is incurred by not supplying the item, the item will be supplied but written justification will be required from the prescribing clinician and sent to the Medical Director of the relevant division."
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.5,
                "text": "Initiation of non- formulary medication"
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.5.1 All requests for initiation of non-formulary medicines within the Trust must be made in writing (e.g. email) initially to a site principal clinical lead pharmacist or site pharmacy Head of Department. The designated non-formulary request form (or site equivalent) must be completed by the consultant."
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.5.2 Individual patient formulary requests will be reviewed within the Trust. A decision may be taken to supply the medicine but this will be based on clinical need, cost effectiveness, alternative available options and ongoing approval across the integrated care system to continue therapy (if appropriate). These discussions will involve specialty Clinical Directors and any other relevant stakeholders."
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.5.3 If on discussion with the requesting clinician any immediate and significant risk to patient safety is incurred by not supplying the item, the item will be supplied but written justification will be required from the prescribing clinician and sent to the divisional Medical Director and specialty Clinical Director."
            },
            "type": "ListItem",
            "sequence_num": 183
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.5.4 Clinicians who disagree with the decisions taken can appeal in writing to the Trust Chief Medical Officer who will make the final binding decision."
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "data": {
                "is_heading": 0,
                "text": "8.5.5 Formulary requests for multiple-patients require formal formulary addition applications. Medicine requests subject to use across the integrated care system are managed via the Health & Care Partnership Medicines Optimisation Committee. Hospital-only medicines are managed via the Trust Medicines Assurance Group. All requests must be made via the principal clinical lead pharmacists or site pharmacy Head of Department."
            },
            "type": "ListItem",
            "sequence_num": 185
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Prescriber expectations and clinical prescribing considerations"
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "The guidelines for prescription writing displayed on the online (internet) version of the British National Formulary (BNF) must always be followed."
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "All prescribing is expected to be based on evidence-based sources, such as published guidance from NICE, professional bodies, the Mid & South Essex integrated care system and the Trust. Trust guidance is published on the intranet. Online versions of key reference sources (BNF and Medusa Injectables Guide) should be consulted for prescribing decisions when required."
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "It is expected that prescribers ask for support to locate appropriate resources and ask for specialist advice where there is any doubt when prescribing. Pharmacists are available 24/7 for advice."
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "Prescribers are responsible for ensuring the prescription is appropriate for individual patient. Individual factors that must be considered for each prescription include:"
            },
            "type": "ListItem",
            "sequence_num": 190
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patient history & allergy status;"
            },
            "type": "ListItem",
            "sequence_num": 191
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Drug history of medicines taken pre-admission to hospital;"
            },
            "type": "ListItem",
            "sequence_num": 192
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Other drugs currently prescribed on additional paper drug charts. Care must be taken to consider any drug-drug interactions or duplications for drugs which have already been prescribed on ePMA systems (where used);"
            },
            "type": "ListItem",
            "sequence_num": 193
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Co-morbidities;"
            },
            "type": "ListItem",
            "sequence_num": 194
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Age;"
            },
            "type": "ListItem",
            "sequence_num": 195
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Current weight;"
            },
            "type": "ListItem",
            "sequence_num": 196
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Organ status: i.e. hepatic and renal function (taking into account both acute and chronic disease states as doses may need alteration if acute injury is corrected);"
            },
            "type": "ListItem",
            "sequence_num": 197
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Whether the patient is pregnant and impact of the medicine on the unborn child;"
            },
            "type": "ListItem",
            "sequence_num": 198
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Other relevant biochemical information."
            },
            "type": "ListItem",
            "sequence_num": 199
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.5,
                "text": "ePMA support features"
            },
            "type": "ListItem",
            "sequence_num": 200
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.5.1 Pre-fixed dosing and prescribing guidance is utilised in ePMA. Prescribers are expected to consider these, and modify if safe and appropriate, before completing the prescription."
            },
            "type": "ListItem",
            "sequence_num": 201
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.5.2 Clinical Decision Support (CDS) within Wellsky ePMA provides prescriber information at the point of prescribing:"
            },
            "type": "ListItem",
            "sequence_num": 202
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Drug-Drug Interactions;"
            },
            "type": "ListItem",
            "sequence_num": 203
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Duplicate drugs;"
            },
            "type": "ListItem",
            "sequence_num": 204
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Therapeutic duplicate drugs;"
            },
            "type": "ListItem",
            "sequence_num": 205
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prescribing of drugs that a patient is allergic."
            },
            "type": "ListItem",
            "sequence_num": 206
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.5.3 If a prescriber still wishes to proceed and prescribe a drug after receiving a CDS warning they can do so by choosing an override reason from the dropdown list. Prescribers are wholly responsible for overriding all such warnings. Wellsky ePMA is configured to display higher level drug interactions (i.e. ones which are most likely to be clinically significant). Therefore not all drug interaction warnings will appear on screen. These warnings are for prescribing support only and they do not replace a prescriber's responsibility to ensure a drug is safe for their patient before prescribing."
            },
            "type": "ListItem",
            "sequence_num": 207
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.6,
                "text": "Providing patient and carer information"
            },
            "type": "ListItem",
            "sequence_num": 208
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.6.1 It is important that the patient (or carer if appropriate) receives adequate information about their medicines unless their documented care plan deems it inappropriate."
            },
            "type": "ListItem",
            "sequence_num": 209
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.6.2 The patient should know as a minimum BEFORE a medicine is commenced:"
            },
            "type": "ListItem",
            "sequence_num": 210
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The purpose of the medicine, including an overview of benefits versus risks of the treatment;"
            },
            "type": "ListItem",
            "sequence_num": 211
        },
        {
            "data": {
                "is_heading": 0,
                "text": "How to take it;"
            },
            "type": "ListItem",
            "sequence_num": 212
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For how long it is to be taken for;"
            },
            "type": "ListItem",
            "sequence_num": 213
        },
        {
            "data": {
                "is_heading": 0,
                "text": "What side effects they may experience;"
            },
            "type": "ListItem",
            "sequence_num": 214
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Any relevant safety-netting guidance/advice in the event of adverse effects to treatment."
            },
            "type": "ListItem",
            "sequence_num": 215
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.6.3 The prescriber is responsible for provision of this information but may be supported by the pharmacy, nursing and midwifery multi-disciplinary team. An entry should be recorded in the patient health record of information provided."
            },
            "type": "ListItem",
            "sequence_num": 216
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.7,
                "text": "Cultural and religious beliefs, lifestyle, patient choice"
            },
            "type": "ListItem",
            "sequence_num": 217
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.7.1 All prescribers must take account of individual patient factors when prescribing and their impact on adherence to a medicine. Some medication may be unsuitable for certain religious groups (e.g. contains pork derivatives) or administration may be affected by fasting."
            },
            "type": "ListItem",
            "sequence_num": 218
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.7.2 Patients with a particular lifestyle may have a different view on an appropriate therapy. This must be considered alongside best practice, safety and guidelines in place such as NICE, formulary etc."
            },
            "type": "ListItem",
            "sequence_num": 219
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.7.3 Prescribers should document that they have considered these in consultation with the patient."
            },
            "type": "ListItem",
            "sequence_num": 220
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.8,
                "text": "Prescribing a patients pre-hospital medicines"
            },
            "type": "ListItem",
            "sequence_num": 221
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.8.1 The medical/surgical team caring for the patient is responsible for ensuring continuity of treatment on patient admission to hospital. All medicines the patient was taking before admission should be clinically reviewed and prescribed as soon as possible."
            },
            "type": "ListItem",
            "sequence_num": 222
        },
        {
            "data": {
                "is_heading": 1,
                "text": "9.8.2 Where possible, pharmacy staff will have documented medicines reconciliation in the designated section of the paper drug chart or as a designated note on Wellsky ePMA. Prescribers are expected to refer to these communications each time they view a chart, or are advised directly by a registered pharmacist or pharmacy technician. Discrepancies should be reviewed and actioned in a timely manner, documenting reasons for changes, in accordance with MSEPO-21090 Medicines Reconciliation Policy."
            },
            "type": "ListItem",
            "sequence_num": 223
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.9,
                "text": "Prescribing medicines for administration when patient is categorised Nil-by- Mouth"
            },
            "type": "ListItem",
            "sequence_num": 224
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.9.1 In some circumstances oral medicines may be administered with small sips of water when the patient is made \u2018nil-by-mouth' (NBM). There are different levels of NBM. Please refer to MSEPO-21128 Administration of medicines policy."
            },
            "type": "ListItem",
            "sequence_num": 225
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.9.2 Prescribers should decide which level of NBM is appropriate for their patient and communicate this to the nursing/midwifery staff. The NBM status of their patient MUST be documented in the patient health record and drug chart/ePMA."
            },
            "type": "ListItem",
            "sequence_num": 226
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Prescribing for children (all persons under  years old)."
            },
            "type": "ListItem",
            "sequence_num": 227
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.10.1 Although for some medicines adult doses are used in older children, this must be checked on a case by case and drug by drug basis. The BNF for Children covers ages from birth up to 18 years old. Always refer to the electronic version available free via the intranet or smartphone app."
            },
            "type": "ListItem",
            "sequence_num": 228
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.10.2 All prescriptions/charts for medicines for children must have age, current weight and intended dose in dose per kilogram (e.g. mg/kg) stated."
            },
            "type": "ListItem",
            "sequence_num": 229
        },
        {
            "data": {
                "is_heading": 0,
                "text": "9.10.3 The following points must be taken into consideration:"
            },
            "type": "ListItem",
            "sequence_num": 230
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The pharmacodynamics and pharmacokinetics of a drug can be very different in children compared to adults, and must be considered as part of the prescribing process in order to minimise toxicity and side effects."
            },
            "type": "ListItem",
            "sequence_num": 231
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Alternative national and specialist centre (e.g. Great Ormond Street) guidelines exist for a range of conditions which may be used in conjunction with the BNFc where this is approved locally."
            },
            "type": "ListItem",
            "sequence_num": 232
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "General principles for using ePMA and paper drug charts"
            },
            "type": "ListItem",
            "sequence_num": 233
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "All prescribing on ePMA systems or paper stationery and charts are part of the patients' legal health record. Therefore all professional standards with respect to documenting in patient health records must be adhered to. Refer to MSEPO-20239 Clinical record keeping standards policy."
            },
            "type": "ListItem",
            "sequence_num": 234
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "All medicines for patients under the care of the Trust must be prescribed on official Trust ePMA systems or Trust prescription stationery (or site equivalent)."
            },
            "type": "ListItem",
            "sequence_num": 235
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "When patients are transferred from another Trust, prescriptions must be rewritten immediately onto the Trust ePMA system or paper prescription chart (where used)."
            },
            "type": "ListItem",
            "sequence_num": 236
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.4,
                "text": "All prescriptions must be dated and signed by the prescriber and endorsed with the prescriber's name in block capitals, including a hospital bleep number, where they hold one. In ePMA dates and prescriber identification are applied automatically."
            },
            "type": "ListItem",
            "sequence_num": 237
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.5,
                "text": "The prescriber must ensure that all newly prescribed or changed medicines requiring urgent administration (i.e. cannot be delayed until next medicine round) are promptly communicated to the administering practitioner (nurse/midwife etc.) caring for the patient."
            },
            "type": "ListItem",
            "sequence_num": 238
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.6,
                "text": "ePMA"
            },
            "type": "ListItem",
            "sequence_num": 239
        },
        {
            "data": {
                "is_heading": 1,
                "text": "10.6.1 Prescriptions for inpatients must be prescribed on the Wellsky ePMA or Metavision ePMA in all areas where these systems operate, without exception."
            },
            "type": "ListItem",
            "sequence_num": 240
        },
        {
            "data": {
                "is_heading": 0,
                "text": "10.6.2 The only exceptions are where it is not possible to safely prescribe electronically, as detailed within ePMA training. In such instances the relevant paper supplementary drug chart is used."
            },
            "type": "ListItem",
            "sequence_num": 241
        },
        {
            "data": {
                "is_heading": 0,
                "text": "10.6.3 Where a supplementary drug chart is used, the prescriber must \u2018prescribe' the relevant \u2018prescription chart' (e.g. \u2018Infusions Chart') on Wellsky ePMA. This is essential to signpost to the administering person of the supplementary prescription on paper."
            },
            "type": "ListItem",
            "sequence_num": 242
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.7,
                "text": "Paper drug charts & prescriptions general principles"
            },
            "type": "ListItem",
            "sequence_num": 243
        },
        {
            "data": {
                "is_heading": 0,
                "text": "10.7.1 All blank paper prescription charts / forms are controlled stationery and must be stored in such a manner as to avoid use by non-appropriate persons. For paper outpatient stationary refer to MSEPO-21187 Order and supply of paper hospital- only outpatient prescription and MSEPO-21005 FP10 Prescription Policy and Procedures."
            },
            "type": "ListItem",
            "sequence_num": 244
        },
        {
            "data": {
                "is_heading": 0,
                "text": "10.7.2 Each site has a designated inpatient prescription chart (the main inpatient chart) that must be used in absence of ePMA (see above). Different main inpatient charts may exist for paediatric and neonatal patients."
            },
            "type": "ListItem",
            "sequence_num": 245
        },
        {
            "data": {
                "is_heading": 0,
                "text": "10.7.3 If a second prescription chart is necessary all charts must be endorsed \u201cChart 1 of 2\u201d, etc. A second chart should only be used when the number of prescribed drugs exceeds the space available on one prescription chart."
            },
            "type": "ListItem",
            "sequence_num": 246
        },
        {
            "data": {
                "is_heading": 0,
                "text": "10.7.4 When a second or subsequent card is started all prescriptions shall be re-written by a doctor or another member of staff accredited to re-write prescriptions e.g. pharmacist or pharmacy technician (where capacity allows)."
            },
            "type": "ListItem",
            "sequence_num": 247
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.8,
                "text": "A new drug chart must be written on each occasion that a patient is admitted or readmitted after discharge. Patients going on home leave (e.g. over a weekend) are not discharged but have their admission suspended."
            },
            "type": "ListItem",
            "sequence_num": 248
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.9,
                "text": "Prescriptions must be re-written before the last administration record column has been used to ensure treatment is continued to be given. The prescription is no longer valid beyond the designated number of days/columns printed on the chart."
            },
            "type": "ListItem",
            "sequence_num": 249
        },
        {
            "data": {
                "is_heading": 0,
                "text": "10.9.1 Supplementary charts exist for specialist situations and these include (but are not exhaustive to):"
            },
            "type": "ListItem",
            "sequence_num": 250
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Continuous Subcutaneous Infusion via Syringe Pump;"
            },
            "type": "ListItem",
            "sequence_num": 251
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Infusions (Chart I);"
            },
            "type": "ListItem",
            "sequence_num": 252
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Unfractionated Heparin;"
            },
            "type": "ListItem",
            "sequence_num": 253
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Variable Rate Intravenous Insulin Infusion;"
            },
            "type": "ListItem",
            "sequence_num": 254
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Diabetic Ketoacidosis;"
            },
            "type": "ListItem",
            "sequence_num": 255
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Emergency department;"
            },
            "type": "ListItem",
            "sequence_num": 256
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Day Case/Day Unit Chart;"
            },
            "type": "ListItem",
            "sequence_num": 257
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Parenteral nutrition;"
            },
            "type": "ListItem",
            "sequence_num": 258
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Intravenous immunoglobulins;"
            },
            "type": "ListItem",
            "sequence_num": 259
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Opiate infusions (where not on ePMA)."
            },
            "type": "ListItem",
            "sequence_num": 260
        },
        {
            "data": {
                "is_heading": 0,
                "text": "10.9.2 All supplementary charts in use must be cross referenced on the front of the main treatment chart in the designated section."
            },
            "type": "ListItem",
            "sequence_num": 261
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.1,
                "text": "Electronic scanned copies of prescriptions"
            },
            "type": "ListItem",
            "sequence_num": 262
        },
        {
            "data": {
                "is_heading": 0,
                "text": "10.10.1  Under current legislation, a scanned prescription is not a legal document, and is not acceptable as the sole authority from which a prescription may be dispensed. However, until a pharmacist can verify the original prescription, pharmacy will accept scanned prescription cards from offsite locations an acceptable prescription order request. This is distinct from an electronically-generated prescription from Wellsky ePMA."
            },
            "type": "ListItem",
            "sequence_num": 263
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Prescribing requirements for inpatient drug charts"
            },
            "type": "ListItem",
            "sequence_num": 264
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "This section mainly applies to paper drug charts, as many requirements are auto populated in ePMA. However, it remains the responsibility of the prescriber to ensure the correct patient and correct medicine particulars have been selected in ePMA BEFORE selecting confirm (i.e. prescribing)."
            },
            "type": "ListItem",
            "sequence_num": 265
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "All prescribers should use BLACK indelible ink on paper charts, preferably a ballpoint (Biro\u00ae) pen that will not smudge or bleed if the chart is accidently splashed."
            },
            "type": "ListItem",
            "sequence_num": 266
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.3,
                "text": "Enter all patient details on every paper chart or apply a Trust addressograph sticker. The prescriber must ensure all required information is provided as follows:"
            },
            "type": "ListItem",
            "sequence_num": 267
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patient's FULL name (first name, surname);"
            },
            "type": "ListItem",
            "sequence_num": 268
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS number;"
            },
            "type": "ListItem",
            "sequence_num": 269
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Site hospital number (where used);"
            },
            "type": "ListItem",
            "sequence_num": 270
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Date of birth;"
            },
            "type": "ListItem",
            "sequence_num": 271
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Weight (in kg);"
            },
            "type": "ListItem",
            "sequence_num": 272
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Allergy and sensitivity status (in accordance with MSBPO-18020 Allergy status management policy), including type of reaction to each entry. Allergy status must be written on every page with an allergies section for paper charts."
            },
            "type": "ListItem",
            "sequence_num": 273
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Requirements for each prescribed medicine"
            },
            "type": "ListItem",
            "sequence_num": 274
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "Once prescribed, all treatment must be kept under regular review by the prescriber responsible for that patient's care and discontinued when no longer required. This must be done in accordance with this policy."
            },
            "type": "ListItem",
            "sequence_num": 275
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "Each and every item prescribed must have the following stated as a minimum (outpatient and inpatient):"
            },
            "type": "ListItem",
            "sequence_num": 276
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Approved name of the medicine;"
            },
            "type": "ListItem",
            "sequence_num": 277
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Formulation (e.g. tablet, suppository);"
            },
            "type": "ListItem",
            "sequence_num": 278
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Strength (e.g. 10mg, 50mg/5ml), written in full or only using approved abbreviations (see appendix 1);"
            },
            "type": "ListItem",
            "sequence_num": 279
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Dose;"
            },
            "type": "ListItem",
            "sequence_num": 280
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Timing and frequency (by circling the relevant pre-printed time or manually entering another specified time using the 24-hour clock);"
            },
            "type": "ListItem",
            "sequence_num": 281
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Duration (if a finite course);"
            },
            "type": "ListItem",
            "sequence_num": 282
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Route (e.g. oral, IV etc.), written in full or only using approved abbreviations (see appendix 1);"
            },
            "type": "ListItem",
            "sequence_num": 283
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Site of application for special treatment (e.g. eczema, to left eye etc.);"
            },
            "type": "ListItem",
            "sequence_num": 284
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Signature of the prescriber AND bleep number printed underneath for ease of identification."
            },
            "type": "ListItem",
            "sequence_num": 285
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.2.1  For outpatients also refer to MSEPO-21187 Order and supply of paper hospital-only outpatient prescription and MSEPO-21005 FP10 Prescription Policy and Procedures."
            },
            "type": "ListItem",
            "sequence_num": 286
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.3,
                "text": "Medicines and other permitted items (as per this policy) must be prescribed in the correct section of the drug chart to their intended use (e.g. once only, regular, when required, antimicrobials, infusion etc.). In ePMA the correct section must be selected in accordance with ePMA training."
            },
            "type": "ListItem",
            "sequence_num": 287
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.4,
                "text": "All instructions for administration must be in English. Block CAPITALS is recommended to ensure a clearly readable prescription is provided. Illegibility of handwriting is a common cause of delayed treatment and/or errors where mis- interpreted."
            },
            "type": "ListItem",
            "sequence_num": 288
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.5,
                "text": "Only approved abbreviations listed in the British National Formulary (BNF) or appendix 1 of this policy should be used. Abbreviations of medicine names must not be used as interpretations can differ. When a medicine is prescribed in units (e.g. insulin, heparins, and some vitamins) units must be written in full, and never abbreviated in any way."
            },
            "type": "ListItem",
            "sequence_num": 289
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.6,
                "text": "Instructions about the route, dose and frequency must be specific and never left as alternatives (i.e. 1 or 2), except for PRN medications where it may be appropriate to prescribe a dose range (e.g. weak analgesics)."
            },
            "type": "ListItem",
            "sequence_num": 290
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.7,
                "text": "Prescribing by approved drug name"
            },
            "type": "ListItem",
            "sequence_num": 291
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.7.1 Medicines should be prescribed generically by the recommended International Non- proprietary Name (rINN). Within Wellsky ePMA this is pre-configured except where drug names have been optimised locally on grounds of patient safety to mitigate accidental mis-selection."
            },
            "type": "ListItem",
            "sequence_num": 292
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.7.2 There are exceptions to generic prescribing where the BRAND must be prescribed. These are:"
            },
            "type": "ListItem",
            "sequence_num": 293
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Specific medicines where bioavailability is a concern;"
            },
            "type": "ListItem",
            "sequence_num": 294
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Drug combinations within one medicine (e.g. some inhalers, eye drops etc.);"
            },
            "type": "ListItem",
            "sequence_num": 295
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patient safety reasons to avoid mis-selection (e.g. insulins)."
            },
            "type": "ListItem",
            "sequence_num": 296
        },
        {
            "data": {
                "is_heading": 1,
                "text": "12.7.3 Anti-epileptic drug brands"
            },
            "type": "ListItem",
            "sequence_num": 297
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Different antiepileptic drugs (AEDs) vary considerably in their characteristics, which influences the risk of whether switching between different manufacturers' products of a particular drug may cause adverse effects or loss of seizure control."
            },
            "type": "ListItem",
            "sequence_num": 298
        },
        {
            "data": {
                "is_heading": 0,
                "text": "AEDs have been divided into three risk-based categories that prescribers and pharmacy staff must consult when deciding whether it is necessary to maintain continuity of supply of a specific manufacturer's product."
            },
            "type": "ListItem",
            "sequence_num": 299
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If deemed appropriate, the exact brand must be prescribed."
            },
            "type": "ListItem",
            "sequence_num": 300
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Refer to MHRA Drug Safety Update guidance as per references to this policy."
            },
            "type": "ListItem",
            "sequence_num": 301
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.8,
                "text": "Prescribing a drug which is not available in Wellsky ePMA"
            },
            "type": "ListItem",
            "sequence_num": 302
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.8.1 Rarely a drug may not be available to prescribe in Wellsky ePMA. This may be a non-formulary drug or a rarely used medicine which has not yet been used by an inpatient. If a drug is not available to prescribe on Wellsky ePMA the ward pharmacist must be contacted by the prescriber immediately. The drug will be assessed for appropriateness in accordance with protocols (e.g. formulary assessment). If approved a drug file will be built to allow it to be prescribed in Wellsky ePMA."
            },
            "type": "ListItem",
            "sequence_num": 303
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.8.2 In the event that the drug needs to be administered urgently or prescribing is taking place out of normal office hours the prescriber can prescriber an UNKNOWN DRUG. Refer to ePMA guideline."
            },
            "type": "ListItem",
            "sequence_num": 304
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.8.3 Queries with unavailable drugs are managed directly between the prescriber and ward pharmacist before pharmacist referral to the ePMA team."
            },
            "type": "ListItem",
            "sequence_num": 305
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.9,
                "text": "Strengths and quantities of medicines"
            },
            "type": "ListItem",
            "sequence_num": 306
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.9.1 Always prescribe doses in weight metrics."
            },
            "type": "ListItem",
            "sequence_num": 307
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.9.2 When prescribing strengths and quantities clarity is essential to avoid drug errors:"
            },
            "type": "ListItem",
            "sequence_num": 308
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Avoid unnecessary use of decimal points e.g. 3mg, not 3.0mg;"
            },
            "type": "ListItem",
            "sequence_num": 309
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Quantities of 1 gram or more should be written as 1g etc;"
            },
            "type": "ListItem",
            "sequence_num": 310
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Quantities less than 1 gram must be written in milligrams (e.g. 500mg, not 0.5g);"
            },
            "type": "ListItem",
            "sequence_num": 311
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Quantities less than 1mg must be written in micrograms (e.g. 100microgram, not 0.1mg);"
            },
            "type": "ListItem",
            "sequence_num": 312
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Micrograms and nanograms must be written in full;"
            },
            "type": "ListItem",
            "sequence_num": 313
        },
        {
            "data": {
                "is_heading": 0,
                "text": "When the use of a decimal is unavoidable, a zero must always be written in front of the decimal point where there is no other figure (e.g. 0.5ml not .5ml)."
            },
            "type": "ListItem",
            "sequence_num": 314
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For all liquids, state the actual dose of the drug, e.g. mg not ml."
            },
            "type": "ListItem",
            "sequence_num": 315
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.1,
                "text": "Routes"
            },
            "type": "ListItem",
            "sequence_num": 316
        },
        {
            "data": {
                "is_heading": 1,
                "text": "12.10.1 Prescribe ONE route of administration per prescription. It is not acceptable to prescribe alternative routes of administration, e.g. IV / Oral, except where the bioavailability of the dose is identical."
            },
            "type": "ListItem",
            "sequence_num": 317
        },
        {
            "data": {
                "is_heading": 1,
                "text": "12.10.2 Prescribe ONLY ONE route of paracetamol per prescription. Never prescribe IV/PO because doses may not be interchangeable. Refer to MSEGL-21017 Paracetamol dosing in high-risk adult patients Guideline."
            },
            "type": "ListItem",
            "sequence_num": 318
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.11,
                "text": "Once only (STAT) medicines"
            },
            "type": "ListItem",
            "sequence_num": 319
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.11.1  Medicines that are intended to be given as a single dose are prescribed in the \u2018once only' (STAT) section. These are either critical medicines to be given immediately or a single dose treatment. The prescriber must ensure the administering person (i.e. nurse) is notified as soon as possible after prescribing."
            },
            "type": "ListItem",
            "sequence_num": 320
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.12,
                "text": "Regular medicines"
            },
            "type": "ListItem",
            "sequence_num": 321
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.13,
                "text": "These are administered on the days, at the times specified, until the prescription is cancelled or instructions are given to the contrary (i.e. a stop date is prescribed and administration boxes are crossed off a paper drug chart, where used)."
            },
            "type": "ListItem",
            "sequence_num": 322
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.14,
                "text": "When Required medicines (PRN)"
            },
            "type": "ListItem",
            "sequence_num": 323
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.14.1 Medicines that may be given at the nurse's discretion according to the needs of the patient are prescribed as PRN."
            },
            "type": "ListItem",
            "sequence_num": 324
        },
        {
            "data": {
                "is_heading": 1,
                "text": "12.14.2 In addition to standard requirements, prescriptions for medicines to be given when required shall include:"
            },
            "type": "ListItem",
            "sequence_num": 325
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The maximum frequency within 24 hours"
            },
            "type": "ListItem",
            "sequence_num": 326
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "Or the maximum dosage / number of doses in  hours."
            },
            "type": "ListItem",
            "sequence_num": 327
        },
        {
            "data": {
                "is_heading": 0,
                "text": "AND the reason for treatment (e.g. for nausea)."
            },
            "type": "ListItem",
            "sequence_num": 328
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.14.3 PRN \u2018when required' medicines should be reviewed on a regular basis, consistent with clinical conditions, and cancelled when no longer indicated."
            },
            "type": "ListItem",
            "sequence_num": 329
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Discontinuation, cancellations and alterations to a prescription"
            },
            "type": "ListItem",
            "sequence_num": 330
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "Handwritten prescriptions must not be altered, including never being overwritten. It must always remain clear as to what was intended at the time of the original prescription. If it is necessary to change the route, frequency or dose of the medicine, the prescription must be cancelled and re-written."
            },
            "type": "ListItem",
            "sequence_num": 331
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "Within Wellsky ePMA, the prescription may be modified at any time, and an electronic audit trail is made of all changes and who by. However if changes are required to the route, form or strength the prescription must to be discontinued and re-prescribed e.g. switching Amoxicillin IV to Oral."
            },
            "type": "ListItem",
            "sequence_num": 332
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.3,
                "text": "Reasons for all medication changes should be documented at the time of the change in the patient health record."
            },
            "type": "ListItem",
            "sequence_num": 333
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.4,
                "text": "Requirements for discontinuing a prescription on a drug chart"
            },
            "type": "ListItem",
            "sequence_num": 334
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.4.1 On paper charts draw a vertical line at the end of the last dose that a drug is to be given and a bold strike across the remainder of the administration section, to"
            },
            "type": "ListItem",
            "sequence_num": 335
        },
        {
            "data": {
                "is_heading": 0,
                "text": "prevent further administration being attempted. Initial, date and endorse bleep number against the cancellation."
            },
            "type": "ListItem",
            "sequence_num": 336
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.4.2 Within Wellsky ePMA the discontinuation option is selected and may be customised to discontinue at a specified time. Refer to ePMA training."
            },
            "type": "ListItem",
            "sequence_num": 337
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.5,
                "text": "Instructing for temporary omissions of one or more doses"
            },
            "type": "ListItem",
            "sequence_num": 338
        },
        {
            "data": {
                "is_heading": 1,
                "text": "13.5.1 On paper, if specific doses are to be omitted they should be cancelled individually by a bold X in the individual administration box. This should be documented in the patient health record, and the administering practitioner (i.e. staff nurse) informed."
            },
            "type": "ListItem",
            "sequence_num": 339
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.5.2 Within ePMA the prescription can be selected as \u2018suspend'. Prescribers are expected to be aware that subsequently selecting the \u2018resume' option against the prescription will immediately makes the prescription active. This means it is available for administration from the next dose due. This can be modified manually. Refer to ePMA training."
            },
            "type": "ListItem",
            "sequence_num": 340
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Prescribing non-daily medicines"
            },
            "type": "ListItem",
            "sequence_num": 341
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.1,
                "text": "A small number of medicines are NOT to be taken daily e.g. once weekly, alternate days, every 3 days etc."
            },
            "type": "ListItem",
            "sequence_num": 342
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "Methotrexate is implicated in a NHS England Never Event. In non-cancer use methotrexate MUST be prescribed and administered ONCE a WEEK only. If given too frequently it can result in toxicity and is potentially fatal."
            },
            "type": "ListItem",
            "sequence_num": 343
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.3,
                "text": "Wellsky ePMA"
            },
            "type": "ListItem",
            "sequence_num": 344
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.3.1 Drugs which are always prescribed once-weekly are configured in Wellsky ePMA to only select by day of the week to be administered. Prescribers must not change these frequencies."
            },
            "type": "ListItem",
            "sequence_num": 345
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.3.2 If a dose has been missed or for example a patch has been removed early the drug will then need to be discontinued in ePMA and re prescribed with a new start date and the correct frequency to ensure that the scheduling of future doses is correct."
            },
            "type": "ListItem",
            "sequence_num": 346
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.4,
                "text": "Paper drug charts"
            },
            "type": "ListItem",
            "sequence_num": 347
        },
        {
            "data": {
                "is_heading": 1,
                "text": "14.4.1 The frequency box must clearly state IN WORDS the frequency OR the exact day/s stated (e.g. \u2018every Monday'). Abbreviations are unacceptable."
            },
            "type": "ListItem",
            "sequence_num": 348
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.4.2 State the time of day and dose as per standard prescribing practice."
            },
            "type": "ListItem",
            "sequence_num": 349
        },
        {
            "data": {
                "is_heading": 1,
                "text": "14.4.3 Across the administration grid next to the prescription enter X clearly in each day's administration record box when not to be given. This indicates to the administering person (i.e. nurse) that the dose is not due."
            },
            "type": "ListItem",
            "sequence_num": 350
        },
        {
            "data": {
                "is_heading": 0,
                "text": "14.4.4 On the day/s when the dose is to be administered, draw a bold box around the administration record box when to be given. E.g.:"
            },
            "type": "ListItem",
            "sequence_num": 351
        },
        {
            "type": "table",
            "sequence_num": 352,
            "data": {
                "num_rows": 3,
                "num_cols": 14,
                "table_items": [
                    {
                        "text": "08:00"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "13:00"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "18:00"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "14.4.5 Prescribers must never leave the prescription in any other format."
            },
            "type": "ListItem",
            "sequence_num": 353
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.5,
                "text": "Prescriber actions to take when day of administration is unknown:"
            },
            "type": "ListItem",
            "sequence_num": 354
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Do not prescribe empirically. This risks the patient being given more than one dose within the week and risk of toxicity."
            },
            "type": "ListItem",
            "sequence_num": 355
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensure all possible sources of information are checked (e.g. ask patient, relative/carer, notes etc.)."
            },
            "type": "ListItem",
            "sequence_num": 356
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Contact the ward pharmacy team to assist with medication history information."
            },
            "type": "ListItem",
            "sequence_num": 357
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For non-critical medication escalate to pharmacy for follow-up via direct ward communication."
            },
            "type": "ListItem",
            "sequence_num": 358
        },
        {
            "data": {
                "is_heading": 0,
                "text": "If the medication is a critical medicine (i.e. patient harm may result if not given), the prescriber must make a risk/benefit decision as to whether to prescribe a STAT dose or alternative medicine until the correct dosing regimen is established."
            },
            "type": "ListItem",
            "sequence_num": 359
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where a prescriber has any concerns with regard to the prescribing of a non- daily medicine, they MUST seek appropriate advice before continuing."
            },
            "type": "ListItem",
            "sequence_num": 360
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Antimicrobial therapy"
            },
            "type": "ListItem",
            "sequence_num": 361
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "Please refer to MSEPO-21054 Policy for Management of Antimicrobials."
            },
            "type": "ListItem",
            "sequence_num": 362
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "Prescribing should be in accordance with Trust antimicrobial guidelines."
            },
            "type": "ListItem",
            "sequence_num": 363
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.3,
                "text": "Prescriptions for systemic antimicrobial therapy must always state the indication and duration for which treatment is to be given. All intravenous therapy must be reviewed at 48 hours or sooner for continued appropriateness and the IV discontinued and oral prescribed where appropriate. A record of these details must also be entered in the patient health record."
            },
            "type": "ListItem",
            "sequence_num": 364
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.4,
                "text": "Antimicrobial prescriptions may be amended, where appropriate, by pharmacists in accordance with the Trust antimicrobial guidelines and policy. All amendments are endorsed as per this policy."
            },
            "type": "ListItem",
            "sequence_num": 365
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.5,
                "text": "Empiric antimicrobial prescriptions which are outside of the Trust guidelines (including restricted antimicrobial use) must state the indication and approving microbiologist / antimicrobial specialist pharmacist for its use. This should be endorsed on the paper drug chart or as an \u2018antibiotic indication' note in Wellsky ePMA."
            },
            "type": "ListItem",
            "sequence_num": 366
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.6,
                "text": "Pharmacy may limit supply of unapproved uses of restricted antimicrobials, where appropriate, in order to facilitate urgent prescriber review."
            },
            "type": "ListItem",
            "sequence_num": 367
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Steroid therapy"
            },
            "type": "ListItem",
            "sequence_num": 368
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "All prescribers who initiate steroid prescriptions in adults should to ensure they issue a Steroid Emergency Card to all eligible patients, as outlined in national and"
            },
            "type": "ListItem",
            "sequence_num": 369
        },
        {
            "data": {
                "is_heading": 0,
                "text": "local Trust guidance. This is a requirement in accordance with NHS Patient Safety Alert: Steroid Emergency Card to support early recognition and treatment of adrenal crisis in adults (NHSI, 2020)."
            },
            "type": "ListItem",
            "sequence_num": 370
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.2,
                "text": "Prescribers undertaking standard or scheduled reviews (e.g. in clinics or when authorising prescriptions in inpatient environment) should ensure all eligible patients prescribed steroids have been assessed, and where necessary issued a Steroid Emergency Card (NHSI, 2020)."
            },
            "type": "ListItem",
            "sequence_num": 371
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Medicines subject to pregnancy prevention programmes (PPPs)"
            },
            "type": "ListItem",
            "sequence_num": 372
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "Some medicines are known to be harmful to the unborn child."
            },
            "type": "ListItem",
            "sequence_num": 373
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.2,
                "text": "Specific medicines may be contraindicated in girls and women of childbearing potential, unless the conditions of that particular medicines pregnancy prevention programme are met. These medicines include valproate, thalidomide, isotretinoin and acitretin (this is not an exhaustive list)."
            },
            "type": "ListItem",
            "sequence_num": 374
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.3,
                "text": "The prescriber is responsible for ensuring all conditions of the pregnancy prevention programme are communicated to the patient, re-enforced at regular defined intervals during treatment and this is documented in the patient health record."
            },
            "type": "ListItem",
            "sequence_num": 375
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.4,
                "text": "Patients must be provided with appropriate medication-specific written and verbal information in accordance with the PPP. Refer to the valproate PPP as per references for requirements."
            },
            "type": "ListItem",
            "sequence_num": 376
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.5,
                "text": "Clinical specialties with responsibility for prescribing these medicines must maintaining auditable records of compliance with the required PPP."
            },
            "type": "ListItem",
            "sequence_num": 377
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Intravenous infusion therapy"
            },
            "type": "ListItem",
            "sequence_num": 378
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "Medicines should be given by injection only when the use of any other route is clinically inappropriate, practically impossible or unacceptable to the patient. The necessity for repeated injections/infusions should be regularly reviewed in favour of switching to oral administration as soon as clinically appropriate."
            },
            "type": "ListItem",
            "sequence_num": 379
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.2,
                "text": "Most intravenous infusions are prescribable in Wellsky ePMA and must be prescribed on the system if the drug file is available to select. Otherwise the paper supplementary \u2018Infusions' chart must be used. Where the supplementary paper chart is used, the prescriber must prescribe \u2018Chart I \u2013 Infusions' to notify administering staff that the chart exists for medicines administration."
            },
            "type": "ListItem",
            "sequence_num": 380
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.3,
                "text": "Safe administration diluents, rates and volumes may be pre-fixed within Wellsky ePMA and should not be altered. These are determined by recommendations and national safety guidance which has been verified by a senior pharmacist."
            },
            "type": "ListItem",
            "sequence_num": 381
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.4,
                "text": "Where main inpatient paper charts exist the designated infusions section must be used."
            },
            "type": "ListItem",
            "sequence_num": 382
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.5,
                "text": "Prescribing guidance on rates, volumes, diluents etc. where not pre-populated must be determined by referring to published guidance. The NHS Medusa injectables guide is the Trust approved primary resource, freely accessible via the intranet. If in doubt prescribers must request advice from a pharmacist."
            },
            "type": "ListItem",
            "sequence_num": 383
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.6,
                "text": "The following must be specified on an infusion prescription in addition to the general particulars for prescribing (where not already pre-populated in case of Wellsky ePMA):"
            },
            "type": "ListItem",
            "sequence_num": 384
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Date of administration;"
            },
            "type": "ListItem",
            "sequence_num": 385
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Name of infusion fluid (avoid abbreviations);"
            },
            "type": "ListItem",
            "sequence_num": 386
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Infusion fluid strength (e.g. 0.9%);"
            },
            "type": "ListItem",
            "sequence_num": 387
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Name of drug additive (if applicable). Only include brand name if this is required due to bioavailability differences (refer to Medusa);"
            },
            "type": "ListItem",
            "sequence_num": 388
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Total volume to be administered (infusion fluid +/- drug additive);"
            },
            "type": "ListItem",
            "sequence_num": 389
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Rate;"
            },
            "type": "ListItem",
            "sequence_num": 390
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Duration;"
            },
            "type": "ListItem",
            "sequence_num": 391
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prescriber Signature and bleep number printed."
            },
            "type": "ListItem",
            "sequence_num": 392
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Controlled Drugs"
            },
            "type": "ListItem",
            "sequence_num": 393
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.1,
                "text": "For all prescribing considerations and requirements refer to MSEPO-20237 Controlled Drug Policy."
            },
            "type": "ListItem",
            "sequence_num": 394
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.2,
                "text": "Intravenous opiate therapy"
            },
            "type": "ListItem",
            "sequence_num": 395
        },
        {
            "data": {
                "is_heading": 0,
                "text": "19.2.1  Intravenous opiate therapy requires careful prescribing and administration with on- going monitoring. Opiates for administration by the intravenous route must not be prescribed in clinical areas where there is not the appropriate monitoring available. Generally this is most inpatient wards, except where there is higher level of care beds with appropriately competent and trained staff."
            },
            "type": "ListItem",
            "sequence_num": 396
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Oral and injectable anticoagulants"
            },
            "type": "ListItem",
            "sequence_num": 397
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.1,
                "text": "Oral anticoagulants"
            },
            "type": "ListItem",
            "sequence_num": 398
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.1.1 Prescriptions for oral anticoagulants should, wherever possible, be written by the regular clinical team between the hours of 9am and 5pm on Monday to Friday. On- call doctors should only be required to dose oral anticoagulants at the weekend if the patient's INR is unstable."
            },
            "type": "ListItem",
            "sequence_num": 399
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.1.2 VKA anticoagulants in use are warfarin and very rarely acenocoumarol and phenindione. INR monitoring is required and dosing must not occur without knowing the indication, duration of treatment and current INR. The indication is essential as INR dose ranges vary according to indication."
            },
            "type": "ListItem",
            "sequence_num": 400
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.1.3 Direct oral anticoagulants (DOACs) do not require INR monitoring. They should be dosed in accordance with Trust guidelines, adjusted dependent on drug choice and patient factors."
            },
            "type": "ListItem",
            "sequence_num": 401
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.1.4 All oral anticoagulants must be prescribed on ePMA or where paper charts exist in the designated anticoagulation section, and completed in full."
            },
            "type": "ListItem",
            "sequence_num": 402
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.1.5 All prescriptions must state the number of days of treatment before review. For VKA anticoagulants requiring INR monitoring, the INR target range must be stated clearly in the appropriate field along with regular INR results. The recommended frequency of monitoring should be indicated."
            },
            "type": "ListItem",
            "sequence_num": 403
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.2,
                "text": "Low-Molecular Weight Heparins (LMWHs)"
            },
            "type": "ListItem",
            "sequence_num": 404
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.2.1 Prescribed doses must be adjusted for patient weight and renal function. Patients should be weighed and their renal function checked at the start of therapy, and where applicable, during treatment. Trust guidelines should be followed."
            },
            "type": "ListItem",
            "sequence_num": 405
        },
        {
            "data": {
                "is_heading": 0,
                "text": "20.2.2 All LMWH must be prescribed on ePMA or where paper charts exist in the designated LMWH section, and completed in full."
            },
            "type": "ListItem",
            "sequence_num": 406
        },
        {
            "data": {
                "is_heading": 1,
                "text": "20.2.3 Thromboprophylaxis"
            },
            "type": "ListItem",
            "sequence_num": 407
        },
        {
            "data": {
                "is_heading": 0,
                "text": "VTE assessment is mandatory and must be completed before prescribing. Upon completion of the VTE assessment appropriate thromboprophylaxis must be prescribed based on the patient's risk factors."
            },
            "type": "ListItem",
            "sequence_num": 408
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Mechanical thromboprophylaxis, if indicated, must be prescribed on the drug chart as if a medicine."
            },
            "type": "ListItem",
            "sequence_num": 409
        },
        {
            "data": {
                "is_heading": 1,
                "text": "20.2.4 Unfractionated Heparin"
            },
            "type": "ListItem",
            "sequence_num": 410
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Unfractionated heparin infusions and initial bolus doses (where used), must be prescribed on the designated drug chart/ section of drug chart (depending on site). Additional bolus doses should be prescribed as \u201conce only STAT doses\u201d or on the PRN medications with specific instructions."
            },
            "type": "ListItem",
            "sequence_num": 411
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Insulin"
            },
            "type": "ListItem",
            "sequence_num": 412
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.1,
                "text": "Insulins are dosed in units and the term UNITS must always be written in full and never abbreviated. Abbreviations can and have resulted in overdoses because the abbreviation is misinterpreted."
            },
            "type": "ListItem",
            "sequence_num": 413
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.2,
                "text": "Subcutaneous insulin"
            },
            "type": "ListItem",
            "sequence_num": 414
        },
        {
            "data": {
                "is_heading": 0,
                "text": "21.2.1 Prescribers are expected to be aware that many types of insulin exist with similar sounding and looking names. Selection errors with these are likely to cause patient harm. Always check the insulin name is spelt correctly."
            },
            "type": "ListItem",
            "sequence_num": 415
        },
        {
            "data": {
                "is_heading": 0,
                "text": "21.2.2 Prescribe insulins by brand name and always specify the correct device type the patient is to use (i.e. disposable pen or cartridge)."
            },
            "type": "ListItem",
            "sequence_num": 416
        },
        {
            "data": {
                "is_heading": 0,
                "text": "21.2.3 Prescribe regular immediate-release and bi-phasic insulins at meal times. This is the default timings in Wellsky ePMA."
            },
            "type": "ListItem",
            "sequence_num": 417
        },
        {
            "data": {
                "is_heading": 0,
                "text": "21.2.4 Regular subcutaneous insulin must be prescribed in the designated sections on paper charts."
            },
            "type": "ListItem",
            "sequence_num": 418
        },
        {
            "data": {
                "is_heading": 0,
                "text": "21.2.5 Newly initiated patients on insulin, to continue, must be prescribed subcutaneous insulin needles and be provided with an insulin passport on outpatient and discharge prescriptions. Both of these can be prescribed on drug charts/ePMA to ensure they are ordered from pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 419
        },
        {
            "data": {
                "is_heading": 0,
                "text": "21.2.6 Regular basal (long-acting) insulin should be continued alongside intravenous insulin infusions in accordance with variable rate intravenous insulin infusion Trust guideline and diabetic ketoacidosis Trust guideline (or site equivalents)."
            },
            "type": "ListItem",
            "sequence_num": 420
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.3,
                "text": "Intravenous insulin"
            },
            "type": "ListItem",
            "sequence_num": 421
        },
        {
            "data": {
                "is_heading": 0,
                "text": "21.3.1  Always follow the Trust guidelines for intravenous infusions (variable rate or fixed rate, depending on indication). Separate drug charts / chart sections exist which must always be used for this purpose."
            },
            "type": "ListItem",
            "sequence_num": 422
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Prescribing for outpatients"
            },
            "type": "ListItem",
            "sequence_num": 423
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.1,
                "text": "Prescriptions must be written only on Trust-approved prescription stationary. Refer to MSEPO-21187 Order and supply of paper hospital-only outpatient prescription and MSEPO-21005 FP10 Prescription Policy and Procedures."
            },
            "type": "ListItem",
            "sequence_num": 424
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.2,
                "text": "All required prescribing standards must be written (or electronically generated) as outlined in this policy. Prescriptions completed incorrectly may not be dispensed by the hospital pharmacy or community pharmacy (in case of FP10 issue) as they could be illegal."
            },
            "type": "ListItem",
            "sequence_num": 425
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.3,
                "text": "Requirements of this policy, including formulary adherence equally apply to all forms of outpatient prescription. Inappropriate prescribing is monitored by the department of pharmacy."
            },
            "type": "ListItem",
            "sequence_num": 426
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.4,
                "text": "Prescriptions should not be written for medicines that the patient is already taking, at the same dose, which is already being supplied by the GP."
            },
            "type": "ListItem",
            "sequence_num": 427
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.5,
                "text": "If appropriate the intended duration of treatment should be stated otherwise twenty- eight days of a new treatment will be dispensed. Patients will then obtain further repeat supplies from their GP, where this is agreed under the medicines formulary. If a course of medication is prescribed this will be dispensed i.e. prednisolone reducing dose, in full by the outpatient pharmacy (or outsourced equivalent)."
            },
            "type": "ListItem",
            "sequence_num": 428
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.6,
                "text": "Hospital-only medicines can only be prescribed by Trust prescribers and GPs will not continue further supply. If in doubt refer to the medicines formulary or contact a principal clinical lead pharmacist or site pharmacy Head of Department."
            },
            "type": "ListItem",
            "sequence_num": 429
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.7,
                "text": "A clear contact number / bleep should be provided on hospital outpatient prescriptions to aid resolution of any queries in a timely manner."
            },
            "type": "ListItem",
            "sequence_num": 430
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.8,
                "text": "All particulars entered onto paper outpatient prescriptions and handwritten FP10s prescriptions must be written clearly (i.e. CAPITALS) using a suitable indelible pen. Ballpoint pens (i.e. a Biro\u00ae) are recommended over free-flowing inks because it is essential that the order is readable on the duplication sheet underneath."
            },
            "type": "ListItem",
            "sequence_num": 431
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.9,
                "text": "All prescriptions must be signed and dated by the prescriber in indelible ink to legalise the prescription. For Wellsky ePMA this is only required for where controlled drugs are prescribed. A separate controlled drug prescription sheet must accompany the ePMA prescription. Refer to MSEPO-20237 Controlled Drug Policy."
            },
            "type": "ListItem",
            "sequence_num": 432
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Self-prescribing and for other hospital staff"
            },
            "type": "ListItem",
            "sequence_num": 433
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 23.1,
                "text": "As a general principle staff should not ask or expect colleagues to prescribe for them or their families except when they are seeing them as patients of the Trust. Exceptions to this are limited and detailed below."
            },
            "type": "ListItem",
            "sequence_num": 434
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.2,
                "text": "Self-prescribing by medical staff"
            },
            "type": "ListItem",
            "sequence_num": 435
        },
        {
            "data": {
                "is_heading": 0,
                "text": "23.2.1 Whilst it is acknowledged that self-prescribing is not a practice that should be encouraged, it is recognised that there may be one-off situations in which it is appropriate for pharmacy to dispense prescriptions written for members of the medical staff, these situations may include:"
            },
            "type": "ListItem",
            "sequence_num": 436
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where there is an urgent (emergency) need for the medicine with the purpose of the prescription being to enable them to continue working safely;"
            },
            "type": "ListItem",
            "sequence_num": 437
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where the medicine is part of an established long-term treatment following formal diagnosis and it is difficult to obtain a prescription from the doctor's own general practitioner."
            },
            "type": "ListItem",
            "sequence_num": 438
        },
        {
            "data": {
                "is_heading": 0,
                "text": "23.2.2 Self-prescribing must only be done on a single occasion and further requests will be referred to the site Pharmacy Head of Department and site Medical Director or divisional Medial Director for discussion and approval."
            },
            "type": "ListItem",
            "sequence_num": 439
        },
        {
            "data": {
                "is_heading": 0,
                "text": "23.2.3 The prescription must be written on a valid Trust outpatient prescription."
            },
            "type": "ListItem",
            "sequence_num": 440
        },
        {
            "data": {
                "is_heading": 0,
                "text": "23.2.4 The quantity prescribed will be determined by the nature of the drug and will be approved by a senior pharmacist on duty. It will not normally exceed one month's supply."
            },
            "type": "ListItem",
            "sequence_num": 441
        },
        {
            "data": {
                "is_heading": 0,
                "text": "23.2.5 Prescription charges are payable in accordance with current Department of Health and Social Care requirements."
            },
            "type": "ListItem",
            "sequence_num": 442
        },
        {
            "data": {
                "is_heading": 0,
                "text": "23.2.6 Provisionally registered doctors (i.e.FY1s) and non-medical prescriber's are not allowed to prescribe for themselves or their family members."
            },
            "type": "ListItem",
            "sequence_num": 443
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.3,
                "text": "Prescribing for other staff in circumstance where cannot access GP services, and prescribing will enable the person to remain safely at work"
            },
            "type": "ListItem",
            "sequence_num": 444
        },
        {
            "data": {
                "is_heading": 0,
                "text": "23.3.1 In exceptional circumstances, if their own GP is unable to see them, a hospital doctor may prescribe a small amount of medication for staff through the usual A&E procedure."
            },
            "type": "ListItem",
            "sequence_num": 445
        },
        {
            "data": {
                "is_heading": 0,
                "text": "23.3.2 Prescription charges are payable in accordance with current Department of Health and Social Care requirements."
            },
            "type": "ListItem",
            "sequence_num": 446
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.4,
                "text": "Prescribing for hospital staff for work-related control for infection"
            },
            "type": "ListItem",
            "sequence_num": 447
        },
        {
            "data": {
                "is_heading": 0,
                "text": "23.4.1  When necessary, the Occupational Health Physician will prescribe for a member of staff with a condition that may be hazardous to patients, e.g. MRSA carriers. In the absence of this prescriber, the prescribing will be done by the clinician with responsibility for control of infection."
            },
            "type": "ListItem",
            "sequence_num": 448
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.5,
                "text": "All members of staff who require medication arising from an incident at work should consult Occupational Health and report details of the incident via the incident reporting system."
            },
            "type": "ListItem",
            "sequence_num": 449
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "Private prescriptions"
            },
            "type": "ListItem",
            "sequence_num": 450
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.1,
                "text": "Hospital patients must have medicines prescribed on approved Trust prescription stationary/ePMA (i.e. are considered the approved NHS prescriptions in the Trust)."
            },
            "type": "ListItem",
            "sequence_num": 451
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.2,
                "text": "Exceptionally a private prescription may be appropriate and this must be prior agreed between the consultant and site pharmacy Head of Department (or deputy). This may involve consultation with primary care commissioners."
            },
            "type": "ListItem",
            "sequence_num": 452
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.3,
                "text": "Medical Staff (excluding provisionally registered doctors (i.e. FY1's) may prescribe for their immediate family using a private prescription in exceptional circumstances adhering to GMC prescribing standards (Good practice in prescribing and managing medicines and devices (5th April 2021))."
            },
            "type": "ListItem",
            "sequence_num": 453
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.4,
                "text": "All private prescriptions agreed to be supplied by the Trust pharmacy are charged at private prescription cost as detailed in the relevant pharmacy departmental procedure, and are dispensed at the discretion of the pharmacy department."
            },
            "type": "ListItem",
            "sequence_num": 454
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "Prescribing amendments (Pharmacy and Nursing/Midwifery)"
            },
            "type": "ListItem",
            "sequence_num": 455
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 25.1,
                "text": "Pharmacists play an active role in medication prescribing safety and routinely review prescribed medication at the Trust."
            },
            "type": "ListItem",
            "sequence_num": 456
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 25.2,
                "text": "In certain circumstances a registered pharmacist or registered pharmacy technician (within their competency) may alter the formulation or dose of a prescribed medicine to clarify meaning and facilitate safe administration."
            },
            "type": "ListItem",
            "sequence_num": 457
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 25.3,
                "text": "Registered pharmacy staff and registered nurses may also make such amendments on inpatient prescriptions only where permitted and defined within a protocol. Such protocols may be agreed by either the specialty Consultant(s), divisional senior Nurse and Pharmacist or as approved Trust-wide by the Medicines Assurance Group."
            },
            "type": "ListItem",
            "sequence_num": 458
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 25.4,
                "text": "Outpatient prescriptions must not be amended by anyone other than the prescriber except registered pharmacists in accordance with departmental procedures for hospital only outpatient prescriptions."
            },
            "type": "ListItem",
            "sequence_num": 459
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 25.5,
                "text": "A pharmacist may alter a prescription written by a prescriber in accordance with a protocol for therapeutic substitution which has been agreed by the Medicines Assurance Group."
            },
            "type": "ListItem",
            "sequence_num": 460
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 25.6,
                "text": "In all instances above a prescriber may not be required to be consulted. However in all other situations, and if there is any doubt about the validity or safety of a prescription, registered nurses midwives and pharmacists must always request clarification from the prescriber."
            },
            "type": "ListItem",
            "sequence_num": 461
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 25.7,
                "text": "Pharmacy recording of contributions"
            },
            "type": "ListItem",
            "sequence_num": 462
        },
        {
            "data": {
                "is_heading": 1,
                "text": "25.7.1 All pharmacy staff modifications on Wellsky ePMA must be accompanied by a contribution note which documents the circumstances and rationale for the modification. For paper charts this must be endorsed on the paper drug chart in the designated section."
            },
            "type": "ListItem",
            "sequence_num": 463
        },
        {
            "data": {
                "is_heading": 0,
                "text": "25.7.2 Endorsements (either on paper or within the ePMA contribution note) must make clear as to whether the prescriber has been contacted \u201cpc\u201d, or prescriber not contacted \u201cpnc\u201d. Where a prescriber is contacted the prescribers name must also be detailed. If on paper the endorsement must be accompanied by pharmacy name, signature and date. In ePMA this is applied automatically."
            },
            "type": "ListItem",
            "sequence_num": 464
        },
        {
            "data": {
                "is_heading": 0,
                "text": "25.7.3 Where the prescriber is not contacted, this must be consistent with the above requirements and the professional judgement of the registered pharmacy staff. They must balance the risk/benefit for patient safety from intervening with a prescription, or not."
            },
            "type": "ListItem",
            "sequence_num": 465
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 25.8,
                "text": "Temporary continuation/discontinuation of administration"
            },
            "type": "ListItem",
            "sequence_num": 466
        },
        {
            "data": {
                "is_heading": 0,
                "text": "25.8.1 A registered nurse/midwife or pharmacist may temporarily continue or discontinue the administration of a medicine which has been prescribed by a medical practitioner, if in their professional judgement this course of action is in the best interests of the patient."
            },
            "type": "ListItem",
            "sequence_num": 467
        },
        {
            "data": {
                "is_heading": 0,
                "text": "25.8.2 Any such action must be reported to the prescriber or appropriate doctor oncall immediately and a full explanation recorded in the patient health record."
            },
            "type": "ListItem",
            "sequence_num": 468
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 26.0,
                "text": "Prescribing errors and incidents"
            },
            "type": "ListItem",
            "sequence_num": 469
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.1,
                "text": "Prescribing errors can occur for a variety of reasons and these must be reported and investigated in accordance with MSBPO-20206 Policy for the Management of and Learning from Medication Error Incidents."
            },
            "type": "ListItem",
            "sequence_num": 470
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 26.2,
                "text": "The prescriber must be contacted as soon as possible when an error is detected or suspected. Where they are not readily available the pharmacist must be contacted immediately where there is a clinical urgency for advice."
            },
            "type": "ListItem",
            "sequence_num": 471
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 27.0,
                "text": "Prescribing concerns"
            },
            "type": "ListItem",
            "sequence_num": 472
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 27.1,
                "text": "All concerns regarding prescribing in the Trust will be taken seriously and investigated where required."
            },
            "type": "ListItem",
            "sequence_num": 473
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 27.2,
                "text": "Any prescribing habits that give a member of staff cause for concern either due to quantities, doses or combinations prescribed should in the first instance be discussed with the site pharmacy Head of Department (or their deputy). During this discussion examples of the prescribing giving cause for concern should be given."
            },
            "type": "ListItem",
            "sequence_num": 474
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 27.3,
                "text": "Should the senior pharmacist consider that there is a problem they will initially contact the prescriber to discuss their prescribing and attempt to address and resolve any concerns. Investigations may be undertaken of the prescribing habit using pharmacy prescribing and dispensing records (e.g. Wellsky) and specialist software tools such as ADiOS and Define."
            },
            "type": "ListItem",
            "sequence_num": 475
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 27.4,
                "text": "If the prescriber fails to recognise that there is an issue or refuses to make any change to their practice then the site Medical Director will be informed by the Chief Pharmacist or Deputy Chief Pharmacist. If necessary escalation to the Chief Medical Officer will be undertaken."
            },
            "type": "ListItem",
            "sequence_num": 476
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 27.5,
                "text": "The site Medical Director will review the prescribing and decide on an appropriate course of action."
            },
            "type": "ListItem",
            "sequence_num": 477
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 27.6,
                "text": "If during the initial investigation there is a suspicion that the prescribing may be fraudulent or an attempt to divert medicines, either for personal use or onward sale or supply, the Chief Pharmacist or deputy will immediately involve the Chief Medical Officer and site Medical Director. Pharmacy will also inform the Local Security Management Specialist and the Essex Police Force Intelligence Bureau, if appropriate."
            },
            "type": "ListItem",
            "sequence_num": 478
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 28.0,
                "text": "Training requirements"
            },
            "type": "ListItem",
            "sequence_num": 479
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 28.1,
                "text": "All prescribers undertake a formal programme of study via an approved educational provider, in accordance with legal and regulatory requirements. For non-medical prescribers refer to MSEPO-21079 Non-medical prescribing policy."
            },
            "type": "ListItem",
            "sequence_num": 480
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 28.2,
                "text": "Prescribers must demonstrate ongoing competency in practice via continuing professional development and revalidation processes. These must be in accordance with requirements set out by their professional regulatory body. Prescribers must follow the relevant national prescribing competency framework (see section 6)."
            },
            "type": "ListItem",
            "sequence_num": 481
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 28.3,
                "text": "Wellsky ePMA"
            },
            "type": "ListItem",
            "sequence_num": 482
        },
        {
            "data": {
                "is_heading": 0,
                "text": "28.3.1 Wellksy ePMA training packages are delivered as eLearning via the Trust learning management system. The \u2018Prescribers' module must be completed before access is given to the Wellsky eMPA system. The eLearning package provides sufficient training for safe practice."
            },
            "type": "ListItem",
            "sequence_num": 483
        },
        {
            "data": {
                "is_heading": 0,
                "text": "28.3.2 Prescribers have a responsibility to maintain their competence on Wellsky ePMA and should contact the ePMA support team if additional training or refresher training is required."
            },
            "type": "ListItem",
            "sequence_num": 484
        },
        {
            "data": {
                "is_heading": 0,
                "text": "28.3.3 New medical staff to the Trust each year (the annual summer intake) receive an induction follow up session to support use of ePMA."
            },
            "type": "ListItem",
            "sequence_num": 485
        },
        {
            "data": {
                "is_heading": 0,
                "text": "28.3.4 Business as usual ePMA support team is provided Monday-Friday 9-5pm for all staff queries (permanent and locum), via the dedicated site hotline or via the team email MSE.epma.info@nhs.net . Business as usual out-of-hours ePMA support, (permanent and locum) is provided by Clinical Site Managers. During implementation stages (Trust ePMA project) support is provided on a 24-hour basis via the dedicated site hotline number."
            },
            "type": "ListItem",
            "sequence_num": 486
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 28.4,
                "text": "Shared learning from experience"
            },
            "type": "ListItem",
            "sequence_num": 487
        },
        {
            "data": {
                "is_heading": 0,
                "text": "28.4.1 Medication safety training is delivered via a range of routes including face to face sessions, message of the week, direct ward level communications and NMP forum meetings."
            },
            "type": "ListItem",
            "sequence_num": 488
        },
        {
            "data": {
                "is_heading": 0,
                "text": "28.4.2 Medication Safety bulletins and corporate Patient Safety alerts are disseminated periodically to share learning and best practice for prescribing with a focus on harm avoidance."
            },
            "type": "ListItem",
            "sequence_num": 489
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 29.0,
                "text": "Monitoring and audit"
            },
            "type": "ListItem",
            "sequence_num": 490
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 29.1,
                "text": "Outlined below is the Trust's process of monitoring compliance with, and the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 491
        },
        {
            "type": "table",
            "sequence_num": 492,
            "data": {
                "num_rows": 6,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Prescriptions are accurate"
                    },
                    {
                        "text": "Pharmacy contributions recording"
                    },
                    {
                        "text": "Pharmacy"
                    },
                    {
                        "text": "continuous"
                    },
                    {
                        "text": "Pharmacy Governance Group"
                    },
                    {
                        "text": "Pharmacy Board"
                    },
                    {
                        "text": "Quality of Prescribing"
                    },
                    {
                        "text": "ePMA reports"
                    },
                    {
                        "text": "Pharmacy"
                    },
                    {
                        "text": "continuous"
                    },
                    {
                        "text": "Pharmacy Governance Group"
                    },
                    {
                        "text": "Pharmacy Board"
                    },
                    {
                        "text": "Wellsky ePMA training"
                    },
                    {
                        "text": "Learning management system"
                    },
                    {
                        "text": "HR"
                    },
                    {
                        "text": "continuous"
                    },
                    {
                        "text": "Quality Governance Group by exception"
                    },
                    {
                        "text": "Quality Governance Group"
                    },
                    {
                        "text": "Safe prescribing"
                    },
                    {
                        "text": "Incident reports"
                    },
                    {
                        "text": "Pharmacy and Clinical Divisions"
                    },
                    {
                        "text": "Monthly"
                    },
                    {
                        "text": "Medicines Optimisation and Safety Group"
                    },
                    {
                        "text": "Medicines Assurance Group"
                    },
                    {
                        "text": "Non-formulary prescribing"
                    },
                    {
                        "text": "Wellsky usage reports"
                    },
                    {
                        "text": "Pharmacy"
                    },
                    {
                        "text": "Bi-monthly"
                    },
                    {
                        "text": "Medicines Assurance Group"
                    },
                    {
                        "text": "Quality Governance Group"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 30.0,
                "text": "Approval and implementation"
            },
            "type": "ListItem",
            "sequence_num": 493
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 30.1,
                "text": "All policies, procedures and guidelines will be approved by the Medicines Assurance Group, which is the specialist group with the authority to approve local medication documents. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 494
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 30.2,
                "text": "It is the author's responsibility to inform the Trust staff of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 495
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 31.0,
                "text": "Equality impact assessment"
            },
            "type": "ListItem",
            "sequence_num": 496
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 31.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 497
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 2)"
            },
            "type": "ListItem",
            "sequence_num": 498
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 32.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 499
        },
        {
            "data": {
                "is_heading": 0,
                "text": "General Medical Council (2021). Good practice in prescribing and managing medicines and devices [online] Available at: https://www.gmc-uk.org/- /media/documents/prescribing-guidance-updated-english-20210405_pdf- 85260533.pdf Accessed 29/11/2021."
            },
            "type": "ListItem",
            "sequence_num": 500
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Health and Care Professions Council (2019). Standards for Prescribing [online] Available at: https://www.hcpc-uk.org/standards/standards-relevant-to-education- and-training/standards-for-prescribing/ Accessed 29/11/2021."
            },
            "type": "ListItem",
            "sequence_num": 501
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Medicines and Healthcare products Regulatory Agency (2013). Antiepileptic drugs: new advice on switching between different manufacturers' products for a particular drug Available at: https://www.gov.uk/drug-safety-update/antiepileptic-drugs-new- advice-on-switching-between-different-manufacturers-products-for-a-particular-drug Accessed 29/11/2021."
            },
            "type": "ListItem",
            "sequence_num": 502
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Medicines and Healthcare products Regulatory Agency (2017). Antiepileptic drugs: updated advice on switching between different manufacturers' products [online] Available at: https://www.gov.uk/drug-safety-update/antiepileptic-drugs-updated- advice-on-switching-between-different-manufacturers-products Accessed 29/11/2021."
            },
            "type": "ListItem",
            "sequence_num": 503
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Medicines and Healthcare products Regulatory Agency (2020). Valproate (Epilim, Depakote) pregnancy prevention programme: updated educational materials) [online] Available at: https://www.gov.uk/drug-safety-update/valproate-epilim- depakote-pregnancy-prevention-programme-updated-educational-materials Accessed 29/11/2021."
            },
            "type": "ListItem",
            "sequence_num": 504
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS Improvement (2020). National Patient Safety Alert: Steroid Emergency Card to support early recognition and treatment of adrenal crisis in adults [online] Available at https://www.cas.mhra.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=10 3082 Accessed 29/11/2021."
            },
            "type": "ListItem",
            "sequence_num": 505
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS Improvement (2021). Never Events List 2018 (updated 02.2021) [online]. Available at https://www.england.nhs.uk/wp-content/uploads/2020/11/2018-Never- Events-List-updated-February-2021.pdf Accessed 25/11/2021"
            },
            "type": "ListItem",
            "sequence_num": 506
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All legacy National Patient Safety Agency alerts are available via the NHS England archive available at https://www.england.nhs.uk/patient-safety/patient-safety-alerts/  Locally held copies are kept by the Trust Medication Safety Officer."
            },
            "type": "ListItem",
            "sequence_num": 507
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Patient Safety Agency. (2007). Actions that can make anticoagulant therapy safer. Patient Safety Alert. [online]"
            },
            "type": "ListItem",
            "sequence_num": 508
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Patient Safety Agency. (2010). Preventing fatalities from medication loading doses. Rapid Response Report. [online]"
            },
            "type": "ListItem",
            "sequence_num": 509
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Patient Safety Agency. (2007). Promoting safer use of injectable medicines. Patient Safety Alert. [online]"
            },
            "type": "ListItem",
            "sequence_num": 510
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Patient Safety Agency. (2010). Reducing treatment dose errors with low molecular weight heparins. Rapid Response Report. [online]"
            },
            "type": "ListItem",
            "sequence_num": 511
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Patient Safety Agency. (2010) Safer Administration of Insulin. Rapid Response Report [online]"
            },
            "type": "ListItem",
            "sequence_num": 512
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Royal Pharmaceutical Society (2021). A Competency Framework for all Prescribers. [online] Available at: https://www.rpharms.com/resources/frameworks/prescribing- competency-framework/competency-framework  Accessed 29/11/2021."
            },
            "type": "ListItem",
            "sequence_num": 513
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Royal Pharmaceutical Society (2021). Medicines Ethics and Practice [online] accessible via https://www.rpharms.com/publications/the-mep  Accessed 23/11/2021 (Registered Pharmacists can access this resource freely of charge if members)."
            },
            "type": "ListItem",
            "sequence_num": 514
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Acceptable Prescribing Abbreviations"
            },
            "type": "ListItem",
            "sequence_num": 515
        },
        {
            "type": "table",
            "sequence_num": 516,
            "data": {
                "num_rows": 8,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Strength"
                    },
                    {
                        "text": "Approved abbreviation"
                    },
                    {
                        "text": "nanogram"
                    },
                    {
                        "text": "nanogram"
                    },
                    {
                        "text": "microgram"
                    },
                    {
                        "text": "microgram"
                    },
                    {
                        "text": "milligram"
                    },
                    {
                        "text": "mg"
                    },
                    {
                        "text": "gram"
                    },
                    {
                        "text": "g"
                    },
                    {
                        "text": "millilitre"
                    },
                    {
                        "text": "mL"
                    },
                    {
                        "text": "millimole"
                    },
                    {
                        "text": "mmol"
                    },
                    {
                        "text": "units"
                    },
                    {
                        "text": "units"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 517,
            "data": {
                "num_rows": 13,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Route"
                    },
                    {
                        "text": "Approved abbreviation"
                    },
                    {
                        "text": "intravenous"
                    },
                    {
                        "text": "IV"
                    },
                    {
                        "text": "intramuscular"
                    },
                    {
                        "text": "IM"
                    },
                    {
                        "text": "subcutaneous"
                    },
                    {
                        "text": "SC"
                    },
                    {
                        "text": "oral"
                    },
                    {
                        "text": "PO"
                    },
                    {
                        "text": "rectal"
                    },
                    {
                        "text": "PR"
                    },
                    {
                        "text": "topical"
                    },
                    {
                        "text": "TOP"
                    },
                    {
                        "text": "inhalation"
                    },
                    {
                        "text": "INH"
                    },
                    {
                        "text": "nebulised / nebuliser"
                    },
                    {
                        "text": "NEB"
                    },
                    {
                        "text": "sublingual"
                    },
                    {
                        "text": "SL"
                    },
                    {
                        "text": "nasogastric"
                    },
                    {
                        "text": "NG"
                    },
                    {
                        "text": "gastrostomy"
                    },
                    {
                        "text": "PEG"
                    },
                    {
                        "text": "nasojejunal"
                    },
                    {
                        "text": "NJ"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prescribing of medicines policy / MSEPO-21226 /1.0"
            },
            "type": "ListItem",
            "sequence_num": 518
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 40.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 519
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Prescribing of medicines policy / MSEPO-21226 /1.0"
            },
            "type": "ListItem",
            "sequence_num": 520
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix2: Preliminary Equality Analysis"
            },
            "type": "ListItem",
            "sequence_num": 521
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to Prescribing of medicines policy: (Please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 522
        },
        {
            "type": "table",
            "sequence_num": 523,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 524,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Harmonised for MSE-wide use"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Harmonised documentation"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Staff and patients have consistent processes applied"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No- in line with best practice"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 & 2."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 525,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Medication Safety Officer"
                    },
                    {
                        "text": "29 November 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 40.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 526
        }
    ]
}